Trial Profile
Phase III study of atamestane plus toremifene [Fareston] versus letrozole [Femara] in advanced breast cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Atamestane (Primary) ; Letrozole; Toremifene
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Intarcia Therapeutics
- 01 Nov 2007 Final results from this study have been published.
- 31 Mar 2006 New trial record.